Nieminen M S, Rapola J, Pellinen T J, Toivonen L
Cardiovascular Laboratory, Central Hospital, Helsinki, Finland.
Ann Clin Res. 1988;20(6):431-5.
Circulatory effects of bopindolol, a new nonselective beta blocking agent with intrinsic sympathomimetic activity and atenolol were compared. After baseline and first dose measurements atenolol 25 mg twice daily and bopindolol 1 mg daily were given to 10 healthy young subjects. Haemodynamic measurements were made noninvasively using echocardiography and systolic time intervals. Clinical and circulatory indices were measured at baseline, after initial dose and after one week of regular treatment at rest and at isometric handgrip exercise (IE) (HG). Atenol reduced the heart rate from 62 bpm to 49 and blunted totally the HR increase during IE (p less than 0.01). Bopindolol caused a 10% fall in heart rate (NS) at rest and a 15% fall (p less than 0.05) during IE. BP fell by 6% after atenol administration and 4% after bopindolol (NS) at rest and similarly during IE. In contrast to bopindolol, atenolol caused small increases initially in left ventricular end-diastolic dimension (LVEDD) and left ventricular end-systolic dimension (LVESD). A 10% increase in FS was seen at rest after bopindolol administration (NS). With the fall in heart rate the estimated cardiac output (CO) also fell from 3.66 to 3.151/min (P less than 0.05) after atenolol but rose from 3.87 to 3.93 after bopindolol (NS) during chronic treatment. Consecutively the total peripheral resistance (TPR) was increased to some extent by atenolol, whereas bopindolol reduced it at rest and during IE. A similar response was also found in systolic time intervals PEP/LVET which were reduced during bopindolol administration.(ABSTRACT TRUNCATED AT 250 WORDS)
比较了一种具有内在拟交感活性的新型非选择性β受体阻滞剂波吲洛尔和美托洛尔的循环系统效应。在进行基线和首剂测量后,对10名健康年轻受试者每日两次给予25毫克美托洛尔,每日一次给予1毫克波吲洛尔。使用超声心动图和收缩期时间间期进行无创血流动力学测量。在基线、首剂后以及静息和等长握力运动(IE)(HG)状态下规律治疗一周后,测量临床和循环系统指标。美托洛尔使心率从62次/分钟降至49次/分钟,并完全抑制了IE期间心率的升高(p<0.01)。波吲洛尔在静息时使心率下降10%(无统计学意义),在IE期间使心率下降15%(p<0.05)。静息时,服用美托洛尔后血压下降6%,服用波吲洛尔后血压下降4%(无统计学意义),IE期间情况类似。与波吲洛尔不同,美托洛尔最初会使左心室舒张末期内径(LVEDD)和左心室收缩末期内径(LVESD)略有增加。服用波吲洛尔后静息时FS增加10%(无统计学意义)。随着心率下降,慢性治疗期间服用美托洛尔后估计的心输出量(CO)也从3.66降至3.15升/分钟(P<0.05),而服用波吲洛尔后从3.87升至3.93(无统计学意义)。连续地,美托洛尔在一定程度上增加了总外周阻力(TPR),而波吲洛尔在静息和IE期间使其降低。在收缩期时间间期PEP/LVET中也发现了类似的反应,服用波吲洛尔期间该指标降低。(摘要截断于250字)